nodes	percent_of_prediction	percent_of_DWPC	metapath
Atenolol—ABCB1—Ezetimibe—atherosclerosis	0.15	0.267	CbGbCtD
Atenolol—ABCB1—Simvastatin—atherosclerosis	0.139	0.248	CbGbCtD
Atenolol—ABCB1—Lovastatin—atherosclerosis	0.136	0.243	CbGbCtD
Atenolol—ABCB1—Pravastatin—atherosclerosis	0.136	0.243	CbGbCtD
Atenolol—Regurgitation—Lovastatin—atherosclerosis	0.0137	0.0369	CcSEcCtD
Atenolol—Regurgitation—Simvastatin—atherosclerosis	0.0128	0.0345	CcSEcCtD
Atenolol—Arterial thrombosis—Niacin—atherosclerosis	0.0107	0.0287	CcSEcCtD
Atenolol—Ache—Lovastatin—atherosclerosis	0.00726	0.0195	CcSEcCtD
Atenolol—Leg pain—Lovastatin—atherosclerosis	0.00726	0.0195	CcSEcCtD
Atenolol—Ache—Simvastatin—atherosclerosis	0.00679	0.0183	CcSEcCtD
Atenolol—Ache—Pravastatin—atherosclerosis	0.00614	0.0165	CcSEcCtD
Atenolol—Systemic lupus erythematosus—Lovastatin—atherosclerosis	0.00606	0.0163	CcSEcCtD
Atenolol—Systemic lupus erythematosus—Simvastatin—atherosclerosis	0.00566	0.0152	CcSEcCtD
Atenolol—Systemic lupus erythematosus—Pravastatin—atherosclerosis	0.00512	0.0138	CcSEcCtD
Atenolol—Hepatic enzyme increased—Rosuvastatin—atherosclerosis	0.00418	0.0112	CcSEcCtD
Atenolol—Ibuprofen—THBD—atherosclerosis	0.00399	0.385	CrCbGaD
Atenolol—Laryngospasm—Niacin—atherosclerosis	0.00386	0.0104	CcSEcCtD
Atenolol—Nightmare—Rosuvastatin—atherosclerosis	0.00382	0.0103	CcSEcCtD
Atenolol—Cholestasis—Niacin—atherosclerosis	0.00379	0.0102	CcSEcCtD
Atenolol—Amnesia—Rosuvastatin—atherosclerosis	0.00306	0.00822	CcSEcCtD
Atenolol—Nightmare—Simvastatin—atherosclerosis	0.00303	0.00814	CcSEcCtD
Atenolol—Nightmare—Pravastatin—atherosclerosis	0.00274	0.00736	CcSEcCtD
Atenolol—Ibuprofen—PLAT—atherosclerosis	0.00274	0.264	CrCbGaD
Atenolol—Vascular purpura—Lovastatin—atherosclerosis	0.00272	0.00731	CcSEcCtD
Atenolol—Amnesia—Lovastatin—atherosclerosis	0.00259	0.00696	CcSEcCtD
Atenolol—Hot flush—Ezetimibe—atherosclerosis	0.00255	0.00686	CcSEcCtD
Atenolol—Vascular purpura—Simvastatin—atherosclerosis	0.00254	0.00684	CcSEcCtD
Atenolol—Amnesia—Ezetimibe—atherosclerosis	0.00254	0.00683	CcSEcCtD
Atenolol—Menopausal symptoms—Ezetimibe—atherosclerosis	0.00253	0.0068	CcSEcCtD
Atenolol—Purpura—Lovastatin—atherosclerosis	0.00253	0.00679	CcSEcCtD
Atenolol—Pain in extremity—Lovastatin—atherosclerosis	0.00243	0.00654	CcSEcCtD
Atenolol—Amnesia—Simvastatin—atherosclerosis	0.00242	0.00651	CcSEcCtD
Atenolol—Atrial fibrillation—Simvastatin—atherosclerosis	0.0024	0.00646	CcSEcCtD
Atenolol—Pain in extremity—Ezetimibe—atherosclerosis	0.00239	0.00642	CcSEcCtD
Atenolol—Purpura—Simvastatin—atherosclerosis	0.00236	0.00635	CcSEcCtD
Atenolol—Vascular purpura—Pravastatin—atherosclerosis	0.0023	0.00618	CcSEcCtD
Atenolol—Depression—Rosuvastatin—atherosclerosis	0.00221	0.00593	CcSEcCtD
Atenolol—Atrial fibrillation—Niacin—atherosclerosis	0.00221	0.00593	CcSEcCtD
Atenolol—Hot flush—Pravastatin—atherosclerosis	0.0022	0.00591	CcSEcCtD
Atenolol—Amnesia—Pravastatin—atherosclerosis	0.00219	0.00589	CcSEcCtD
Atenolol—Menopausal symptoms—Pravastatin—atherosclerosis	0.00218	0.00586	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.00215	0.00578	CcSEcCtD
Atenolol—Purpura—Pravastatin—atherosclerosis	0.00214	0.00574	CcSEcCtD
Atenolol—Disturbance in sexual arousal—Niacin—atherosclerosis	0.00207	0.00557	CcSEcCtD
Atenolol—Affect lability—Pravastatin—atherosclerosis	0.00203	0.00544	CcSEcCtD
Atenolol—Abdominal discomfort—Lovastatin—atherosclerosis	0.00202	0.00542	CcSEcCtD
Atenolol—Mood swings—Pravastatin—atherosclerosis	0.00195	0.00524	CcSEcCtD
Atenolol—Erectile dysfunction—Lovastatin—atherosclerosis	0.00194	0.00521	CcSEcCtD
Atenolol—Orthostatic hypotension—Niacin—atherosclerosis	0.00191	0.00513	CcSEcCtD
Atenolol—Erectile dysfunction—Ezetimibe—atherosclerosis	0.0019	0.00511	CcSEcCtD
Atenolol—Abdominal discomfort—Simvastatin—atherosclerosis	0.00189	0.00507	CcSEcCtD
Atenolol—Erectile dysfunction—Simvastatin—atherosclerosis	0.00181	0.00487	CcSEcCtD
Atenolol—Arrhythmia—Rosuvastatin—atherosclerosis	0.00177	0.00477	CcSEcCtD
Atenolol—Depression—Simvastatin—atherosclerosis	0.00175	0.0047	CcSEcCtD
Atenolol—Erectile dysfunction—Niacin—atherosclerosis	0.00166	0.00447	CcSEcCtD
Atenolol—Erectile dysfunction—Pravastatin—atherosclerosis	0.00164	0.0044	CcSEcCtD
Atenolol—Depression—Pravastatin—atherosclerosis	0.00158	0.00425	CcSEcCtD
Atenolol—Flushing—Lovastatin—atherosclerosis	0.00156	0.0042	CcSEcCtD
Atenolol—Myocardial infarction—Pravastatin—atherosclerosis	0.00155	0.00418	CcSEcCtD
Atenolol—Sweating—Niacin—atherosclerosis	0.00154	0.00415	CcSEcCtD
Atenolol—Flushing—Ezetimibe—atherosclerosis	0.00153	0.00412	CcSEcCtD
Atenolol—Cough—Rosuvastatin—atherosclerosis	0.00151	0.00406	CcSEcCtD
Atenolol—Alopecia—Lovastatin—atherosclerosis	0.00149	0.004	CcSEcCtD
Atenolol—Flushing—Simvastatin—atherosclerosis	0.00146	0.00393	CcSEcCtD
Atenolol—Alopecia—Ezetimibe—atherosclerosis	0.00146	0.00392	CcSEcCtD
Atenolol—Confusional state—Rosuvastatin—atherosclerosis	0.00142	0.00383	CcSEcCtD
Atenolol—Visual impairment—Niacin—atherosclerosis	0.00139	0.00375	CcSEcCtD
Atenolol—Alopecia—Simvastatin—atherosclerosis	0.00139	0.00374	CcSEcCtD
Atenolol—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00138	0.00371	CcSEcCtD
Atenolol—Vision blurred—Lovastatin—atherosclerosis	0.00138	0.00371	CcSEcCtD
Atenolol—Visual impairment—Pravastatin—atherosclerosis	0.00137	0.00369	CcSEcCtD
Atenolol—Ill-defined disorder—Lovastatin—atherosclerosis	0.00136	0.00365	CcSEcCtD
Atenolol—Tinnitus—Niacin—atherosclerosis	0.00135	0.00362	CcSEcCtD
Atenolol—Flushing—Niacin—atherosclerosis	0.00134	0.00361	CcSEcCtD
Atenolol—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00133	0.00358	CcSEcCtD
Atenolol—Tinnitus—Pravastatin—atherosclerosis	0.00133	0.00357	CcSEcCtD
Atenolol—Malaise—Lovastatin—atherosclerosis	0.00132	0.00355	CcSEcCtD
Atenolol—Flushing—Pravastatin—atherosclerosis	0.00132	0.00355	CcSEcCtD
Atenolol—Vertigo—Lovastatin—atherosclerosis	0.00132	0.00354	CcSEcCtD
Atenolol—Malaise—Ezetimibe—atherosclerosis	0.0013	0.00348	CcSEcCtD
Atenolol—Vision blurred—Simvastatin—atherosclerosis	0.00129	0.00347	CcSEcCtD
Atenolol—Arrhythmia—Niacin—atherosclerosis	0.00129	0.00347	CcSEcCtD
Atenolol—Alopecia—Niacin—atherosclerosis	0.00128	0.00343	CcSEcCtD
Atenolol—Insomnia—Rosuvastatin—atherosclerosis	0.00128	0.00343	CcSEcCtD
Atenolol—Ill-defined disorder—Simvastatin—atherosclerosis	0.00127	0.00342	CcSEcCtD
Atenolol—Arrhythmia—Pravastatin—atherosclerosis	0.00127	0.00342	CcSEcCtD
Atenolol—Palpitations—Ezetimibe—atherosclerosis	0.00127	0.00341	CcSEcCtD
Atenolol—Paraesthesia—Rosuvastatin—atherosclerosis	0.00127	0.00341	CcSEcCtD
Atenolol—Ibuprofen—CXCL8—atherosclerosis	0.00126	0.121	CrCbGaD
Atenolol—Alopecia—Pravastatin—atherosclerosis	0.00126	0.00338	CcSEcCtD
Atenolol—Cough—Ezetimibe—atherosclerosis	0.00125	0.00337	CcSEcCtD
Atenolol—Chest pain—Lovastatin—atherosclerosis	0.00125	0.00335	CcSEcCtD
Atenolol—Anxiety—Lovastatin—atherosclerosis	0.00124	0.00334	CcSEcCtD
Atenolol—Dyspepsia—Rosuvastatin—atherosclerosis	0.00124	0.00334	CcSEcCtD
Atenolol—Malaise—Simvastatin—atherosclerosis	0.00124	0.00332	CcSEcCtD
Atenolol—Tension—Niacin—atherosclerosis	0.00124	0.00332	CcSEcCtD
Atenolol—Discomfort—Lovastatin—atherosclerosis	0.00123	0.00331	CcSEcCtD
Atenolol—Vertigo—Simvastatin—atherosclerosis	0.00123	0.00331	CcSEcCtD
Atenolol—Chest pain—Ezetimibe—atherosclerosis	0.00122	0.00329	CcSEcCtD
Atenolol—Nervousness—Niacin—atherosclerosis	0.00122	0.00329	CcSEcCtD
Atenolol—Dry mouth—Lovastatin—atherosclerosis	0.00122	0.00328	CcSEcCtD
Atenolol—Tension—Pravastatin—atherosclerosis	0.00122	0.00327	CcSEcCtD
Atenolol—Discomfort—Ezetimibe—atherosclerosis	0.00121	0.00325	CcSEcCtD
Atenolol—Pain—Rosuvastatin—atherosclerosis	0.00121	0.00324	CcSEcCtD
Atenolol—Constipation—Rosuvastatin—atherosclerosis	0.00121	0.00324	CcSEcCtD
Atenolol—Confusional state—Lovastatin—atherosclerosis	0.00121	0.00324	CcSEcCtD
Atenolol—Nervousness—Pravastatin—atherosclerosis	0.0012	0.00324	CcSEcCtD
Atenolol—Dry mouth—Ezetimibe—atherosclerosis	0.0012	0.00322	CcSEcCtD
Atenolol—Vision blurred—Niacin—atherosclerosis	0.00119	0.00319	CcSEcCtD
Atenolol—Confusional state—Ezetimibe—atherosclerosis	0.00118	0.00318	CcSEcCtD
Atenolol—Thrombocytopenia—Lovastatin—atherosclerosis	0.00117	0.00315	CcSEcCtD
Atenolol—Vision blurred—Pravastatin—atherosclerosis	0.00117	0.00314	CcSEcCtD
Atenolol—Chest pain—Simvastatin—atherosclerosis	0.00117	0.00314	CcSEcCtD
Atenolol—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00116	0.00313	CcSEcCtD
Atenolol—Anxiety—Simvastatin—atherosclerosis	0.00116	0.00313	CcSEcCtD
Atenolol—Discomfort—Simvastatin—atherosclerosis	0.00115	0.0031	CcSEcCtD
Atenolol—Ill-defined disorder—Pravastatin—atherosclerosis	0.00115	0.00309	CcSEcCtD
Atenolol—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00115	0.00309	CcSEcCtD
Atenolol—Anorexia—Lovastatin—atherosclerosis	0.00114	0.00306	CcSEcCtD
Atenolol—Vertigo—Niacin—atherosclerosis	0.00113	0.00304	CcSEcCtD
Atenolol—Syncope—Niacin—atherosclerosis	0.00113	0.00303	CcSEcCtD
Atenolol—Confusional state—Simvastatin—atherosclerosis	0.00113	0.00303	CcSEcCtD
Atenolol—Oedema—Simvastatin—atherosclerosis	0.00112	0.00301	CcSEcCtD
Atenolol—Malaise—Pravastatin—atherosclerosis	0.00112	0.003	CcSEcCtD
Atenolol—Vertigo—Pravastatin—atherosclerosis	0.00111	0.00299	CcSEcCtD
Atenolol—Palpitations—Niacin—atherosclerosis	0.00111	0.00299	CcSEcCtD
Atenolol—Loss of consciousness—Niacin—atherosclerosis	0.00111	0.00297	CcSEcCtD
Atenolol—Cough—Niacin—atherosclerosis	0.0011	0.00295	CcSEcCtD
Atenolol—Thrombocytopenia—Simvastatin—atherosclerosis	0.0011	0.00294	CcSEcCtD
Atenolol—Insomnia—Lovastatin—atherosclerosis	0.00108	0.00291	CcSEcCtD
Atenolol—Cough—Pravastatin—atherosclerosis	0.00108	0.00291	CcSEcCtD
Atenolol—Paraesthesia—Lovastatin—atherosclerosis	0.00107	0.00289	CcSEcCtD
Atenolol—Anorexia—Simvastatin—atherosclerosis	0.00107	0.00287	CcSEcCtD
Atenolol—Dyspnoea—Lovastatin—atherosclerosis	0.00107	0.00287	CcSEcCtD
Atenolol—Insomnia—Ezetimibe—atherosclerosis	0.00106	0.00285	CcSEcCtD
Atenolol—Chest pain—Pravastatin—atherosclerosis	0.00106	0.00284	CcSEcCtD
Atenolol—Paraesthesia—Ezetimibe—atherosclerosis	0.00105	0.00283	CcSEcCtD
Atenolol—Dyspepsia—Lovastatin—atherosclerosis	0.00105	0.00283	CcSEcCtD
Atenolol—Anxiety—Pravastatin—atherosclerosis	0.00105	0.00283	CcSEcCtD
Atenolol—Dry mouth—Niacin—atherosclerosis	0.00105	0.00282	CcSEcCtD
Atenolol—Dyspnoea—Ezetimibe—atherosclerosis	0.00105	0.00281	CcSEcCtD
Atenolol—Discomfort—Pravastatin—atherosclerosis	0.00104	0.0028	CcSEcCtD
Atenolol—Decreased appetite—Lovastatin—atherosclerosis	0.00104	0.00279	CcSEcCtD
Atenolol—Dyspepsia—Ezetimibe—atherosclerosis	0.00103	0.00278	CcSEcCtD
Atenolol—Fatigue—Lovastatin—atherosclerosis	0.00103	0.00277	CcSEcCtD
Atenolol—Oedema—Niacin—atherosclerosis	0.00103	0.00276	CcSEcCtD
Atenolol—Pain—Lovastatin—atherosclerosis	0.00102	0.00275	CcSEcCtD
Atenolol—Constipation—Lovastatin—atherosclerosis	0.00102	0.00275	CcSEcCtD
Atenolol—Confusional state—Pravastatin—atherosclerosis	0.00102	0.00274	CcSEcCtD
Atenolol—Decreased appetite—Ezetimibe—atherosclerosis	0.00102	0.00274	CcSEcCtD
Atenolol—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00101	0.00272	CcSEcCtD
Atenolol—Asthenia—Rosuvastatin—atherosclerosis	0.00101	0.00272	CcSEcCtD
Atenolol—Insomnia—Simvastatin—atherosclerosis	0.00101	0.00272	CcSEcCtD
Atenolol—Oedema—Pravastatin—atherosclerosis	0.00101	0.00272	CcSEcCtD
Atenolol—Fatigue—Ezetimibe—atherosclerosis	0.00101	0.00272	CcSEcCtD
Atenolol—Shock—Niacin—atherosclerosis	0.00101	0.00272	CcSEcCtD
Atenolol—Paraesthesia—Simvastatin—atherosclerosis	0.001	0.0027	CcSEcCtD
Atenolol—Constipation—Ezetimibe—atherosclerosis	0.001	0.0027	CcSEcCtD
Atenolol—Pain—Ezetimibe—atherosclerosis	0.001	0.0027	CcSEcCtD
Atenolol—Tachycardia—Niacin—atherosclerosis	0.001	0.00269	CcSEcCtD
Atenolol—Pruritus—Rosuvastatin—atherosclerosis	0.000999	0.00268	CcSEcCtD
Atenolol—Dyspnoea—Simvastatin—atherosclerosis	0.000997	0.00268	CcSEcCtD
Atenolol—Hyperhidrosis—Niacin—atherosclerosis	0.000993	0.00267	CcSEcCtD
Atenolol—Thrombocytopenia—Pravastatin—atherosclerosis	0.00099	0.00266	CcSEcCtD
Atenolol—Feeling abnormal—Lovastatin—atherosclerosis	0.000986	0.00265	CcSEcCtD
Atenolol—Dyspepsia—Simvastatin—atherosclerosis	0.000985	0.00265	CcSEcCtD
Atenolol—Anorexia—Niacin—atherosclerosis	0.000979	0.00263	CcSEcCtD
Atenolol—Hyperhidrosis—Pravastatin—atherosclerosis	0.000978	0.00263	CcSEcCtD
Atenolol—Decreased appetite—Simvastatin—atherosclerosis	0.000973	0.00261	CcSEcCtD
Atenolol—Feeling abnormal—Ezetimibe—atherosclerosis	0.000967	0.0026	CcSEcCtD
Atenolol—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000966	0.0026	CcSEcCtD
Atenolol—Diarrhoea—Rosuvastatin—atherosclerosis	0.000966	0.0026	CcSEcCtD
Atenolol—Fatigue—Simvastatin—atherosclerosis	0.000965	0.00259	CcSEcCtD
Atenolol—Anorexia—Pravastatin—atherosclerosis	0.000964	0.00259	CcSEcCtD
Atenolol—Hypotension—Niacin—atherosclerosis	0.00096	0.00258	CcSEcCtD
Atenolol—Pain—Simvastatin—atherosclerosis	0.000957	0.00257	CcSEcCtD
Atenolol—Constipation—Simvastatin—atherosclerosis	0.000957	0.00257	CcSEcCtD
Atenolol—Body temperature increased—Lovastatin—atherosclerosis	0.000946	0.00254	CcSEcCtD
Atenolol—Dizziness—Rosuvastatin—atherosclerosis	0.000933	0.00251	CcSEcCtD
Atenolol—Insomnia—Niacin—atherosclerosis	0.000929	0.0025	CcSEcCtD
Atenolol—Body temperature increased—Ezetimibe—atherosclerosis	0.000927	0.00249	CcSEcCtD
Atenolol—Paraesthesia—Niacin—atherosclerosis	0.000922	0.00248	CcSEcCtD
Atenolol—Feeling abnormal—Simvastatin—atherosclerosis	0.000922	0.00248	CcSEcCtD
Atenolol—Dyspnoea—Niacin—atherosclerosis	0.000916	0.00246	CcSEcCtD
Atenolol—Insomnia—Pravastatin—atherosclerosis	0.000915	0.00246	CcSEcCtD
Atenolol—Somnolence—Niacin—atherosclerosis	0.000913	0.00245	CcSEcCtD
Atenolol—Paraesthesia—Pravastatin—atherosclerosis	0.000908	0.00244	CcSEcCtD
Atenolol—Dyspepsia—Niacin—atherosclerosis	0.000904	0.00243	CcSEcCtD
Atenolol—Dyspnoea—Pravastatin—atherosclerosis	0.000902	0.00242	CcSEcCtD
Atenolol—Decreased appetite—Niacin—atherosclerosis	0.000893	0.0024	CcSEcCtD
Atenolol—Dyspepsia—Pravastatin—atherosclerosis	0.00089	0.00239	CcSEcCtD
Atenolol—Rash—Rosuvastatin—atherosclerosis	0.00089	0.00239	CcSEcCtD
Atenolol—Dermatitis—Rosuvastatin—atherosclerosis	0.000889	0.00239	CcSEcCtD
Atenolol—Gastrointestinal disorder—Niacin—atherosclerosis	0.000887	0.00238	CcSEcCtD
Atenolol—Body temperature increased—Simvastatin—atherosclerosis	0.000884	0.00238	CcSEcCtD
Atenolol—Headache—Rosuvastatin—atherosclerosis	0.000884	0.00238	CcSEcCtD
Atenolol—Decreased appetite—Pravastatin—atherosclerosis	0.000879	0.00236	CcSEcCtD
Atenolol—Pain—Niacin—atherosclerosis	0.000879	0.00236	CcSEcCtD
Atenolol—Fatigue—Pravastatin—atherosclerosis	0.000872	0.00234	CcSEcCtD
Atenolol—Ibuprofen—PPARG—atherosclerosis	0.000871	0.0839	CrCbGaD
Atenolol—Constipation—Pravastatin—atherosclerosis	0.000865	0.00232	CcSEcCtD
Atenolol—Pain—Pravastatin—atherosclerosis	0.000865	0.00232	CcSEcCtD
Atenolol—Asthenia—Lovastatin—atherosclerosis	0.000858	0.00231	CcSEcCtD
Atenolol—Pruritus—Lovastatin—atherosclerosis	0.000846	0.00227	CcSEcCtD
Atenolol—Asthenia—Ezetimibe—atherosclerosis	0.000842	0.00226	CcSEcCtD
Atenolol—Nausea—Rosuvastatin—atherosclerosis	0.000838	0.00225	CcSEcCtD
Atenolol—Feeling abnormal—Pravastatin—atherosclerosis	0.000834	0.00224	CcSEcCtD
Atenolol—Pruritus—Ezetimibe—atherosclerosis	0.00083	0.00223	CcSEcCtD
Atenolol—Chlorphenesin—PTGS2—atherosclerosis	0.000824	0.0793	CrCbGaD
Atenolol—Diarrhoea—Lovastatin—atherosclerosis	0.000818	0.0022	CcSEcCtD
Atenolol—Body temperature increased—Niacin—atherosclerosis	0.000812	0.00218	CcSEcCtD
Atenolol—Asthenia—Simvastatin—atherosclerosis	0.000803	0.00216	CcSEcCtD
Atenolol—Diarrhoea—Ezetimibe—atherosclerosis	0.000803	0.00216	CcSEcCtD
Atenolol—Body temperature increased—Pravastatin—atherosclerosis	0.0008	0.00215	CcSEcCtD
Atenolol—Pruritus—Simvastatin—atherosclerosis	0.000792	0.00213	CcSEcCtD
Atenolol—Dizziness—Lovastatin—atherosclerosis	0.000791	0.00213	CcSEcCtD
Atenolol—Dizziness—Ezetimibe—atherosclerosis	0.000776	0.00209	CcSEcCtD
Atenolol—Diarrhoea—Simvastatin—atherosclerosis	0.000766	0.00206	CcSEcCtD
Atenolol—Rash—Lovastatin—atherosclerosis	0.000754	0.00203	CcSEcCtD
Atenolol—Dermatitis—Lovastatin—atherosclerosis	0.000754	0.00203	CcSEcCtD
Atenolol—Headache—Lovastatin—atherosclerosis	0.000749	0.00201	CcSEcCtD
Atenolol—Dizziness—Simvastatin—atherosclerosis	0.00074	0.00199	CcSEcCtD
Atenolol—Rash—Ezetimibe—atherosclerosis	0.00074	0.00199	CcSEcCtD
Atenolol—Dermatitis—Ezetimibe—atherosclerosis	0.000739	0.00199	CcSEcCtD
Atenolol—Asthenia—Niacin—atherosclerosis	0.000737	0.00198	CcSEcCtD
Atenolol—Headache—Ezetimibe—atherosclerosis	0.000735	0.00198	CcSEcCtD
Atenolol—Pruritus—Niacin—atherosclerosis	0.000727	0.00195	CcSEcCtD
Atenolol—Asthenia—Pravastatin—atherosclerosis	0.000726	0.00195	CcSEcCtD
Atenolol—Pruritus—Pravastatin—atherosclerosis	0.000716	0.00192	CcSEcCtD
Atenolol—Nausea—Lovastatin—atherosclerosis	0.000711	0.00191	CcSEcCtD
Atenolol—Rash—Simvastatin—atherosclerosis	0.000705	0.0019	CcSEcCtD
Atenolol—Dermatitis—Simvastatin—atherosclerosis	0.000705	0.00189	CcSEcCtD
Atenolol—Diarrhoea—Niacin—atherosclerosis	0.000703	0.00189	CcSEcCtD
Atenolol—Headache—Simvastatin—atherosclerosis	0.000701	0.00188	CcSEcCtD
Atenolol—Nausea—Ezetimibe—atherosclerosis	0.000697	0.00187	CcSEcCtD
Atenolol—Diarrhoea—Pravastatin—atherosclerosis	0.000692	0.00186	CcSEcCtD
Atenolol—Dizziness—Niacin—atherosclerosis	0.000679	0.00183	CcSEcCtD
Atenolol—Dizziness—Pravastatin—atherosclerosis	0.000669	0.0018	CcSEcCtD
Atenolol—Nausea—Simvastatin—atherosclerosis	0.000665	0.00179	CcSEcCtD
Atenolol—Rash—Niacin—atherosclerosis	0.000648	0.00174	CcSEcCtD
Atenolol—Dermatitis—Niacin—atherosclerosis	0.000647	0.00174	CcSEcCtD
Atenolol—Headache—Niacin—atherosclerosis	0.000644	0.00173	CcSEcCtD
Atenolol—Rash—Pravastatin—atherosclerosis	0.000638	0.00171	CcSEcCtD
Atenolol—Dermatitis—Pravastatin—atherosclerosis	0.000637	0.00171	CcSEcCtD
Atenolol—Headache—Pravastatin—atherosclerosis	0.000634	0.0017	CcSEcCtD
Atenolol—Nausea—Niacin—atherosclerosis	0.00061	0.00164	CcSEcCtD
Atenolol—Nausea—Pravastatin—atherosclerosis	0.000601	0.00161	CcSEcCtD
Atenolol—Ibuprofen—PTGS2—atherosclerosis	0.000368	0.0354	CrCbGaD
Atenolol—Ibuprofen—ALB—atherosclerosis	0.000328	0.0316	CrCbGaD
Atenolol—ADRB1—GPCR ligand binding—AGT—atherosclerosis	7.87e-05	0.00138	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—TGFB1—atherosclerosis	7.84e-05	0.00138	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—AGT—atherosclerosis	7.7e-05	0.00135	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CCL3—atherosclerosis	7.46e-05	0.00131	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	7.46e-05	0.00131	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—EDNRA—atherosclerosis	7.43e-05	0.00131	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—CCR2—atherosclerosis	7.43e-05	0.00131	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—TNF—atherosclerosis	7.33e-05	0.00129	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—LDLRAP1—atherosclerosis	7.32e-05	0.00129	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CCL3—atherosclerosis	7.3e-05	0.00128	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—F2—atherosclerosis	7.27e-05	0.00128	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—EDNRA—atherosclerosis	7.27e-05	0.00128	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—CCR2—atherosclerosis	7.27e-05	0.00128	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—GHRL—atherosclerosis	7.24e-05	0.00127	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—F2—atherosclerosis	7.11e-05	0.00125	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—GHRL—atherosclerosis	7.09e-05	0.00125	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—APOA4—atherosclerosis	7e-05	0.00123	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PLTP—atherosclerosis	6.89e-05	0.00121	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—APOA4—atherosclerosis	6.85e-05	0.0012	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CCR2—atherosclerosis	6.75e-05	0.00119	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—EDNRA—atherosclerosis	6.75e-05	0.00119	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	6.73e-05	0.00118	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CCR2—atherosclerosis	6.6e-05	0.00116	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—EDNRA—atherosclerosis	6.6e-05	0.00116	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	6.58e-05	0.00116	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—GHRL—atherosclerosis	6.58e-05	0.00116	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—CCL2—atherosclerosis	6.48e-05	0.00114	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	6.46e-05	0.00113	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CCL4—atherosclerosis	6.45e-05	0.00113	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—GHRL—atherosclerosis	6.43e-05	0.00113	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—KNG1—atherosclerosis	6.36e-05	0.00112	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—CCL2—atherosclerosis	6.34e-05	0.00111	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—AGTR1—atherosclerosis	6.32e-05	0.00111	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCL4—atherosclerosis	6.31e-05	0.00111	CbGpPWpGaD
Atenolol—ABCB1—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	6.3e-05	0.00111	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—KNG1—atherosclerosis	6.22e-05	0.00109	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—AGTR1—atherosclerosis	6.18e-05	0.00109	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—APOA2—atherosclerosis	6.03e-05	0.00106	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—LTA4H—atherosclerosis	5.97e-05	0.00105	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ABCG8—atherosclerosis	5.97e-05	0.00105	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—APOA2—atherosclerosis	5.9e-05	0.00104	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	5.85e-05	0.00103	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—KNG1—atherosclerosis	5.77e-05	0.00101	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—UTS2—atherosclerosis	5.75e-05	0.00101	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—AGTR1—atherosclerosis	5.74e-05	0.00101	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—KNG1—atherosclerosis	5.65e-05	0.000992	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—UTS2—atherosclerosis	5.63e-05	0.000989	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—AGTR1—atherosclerosis	5.61e-05	0.000986	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CX3CR1—atherosclerosis	5.52e-05	0.000969	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CASR—atherosclerosis	5.52e-05	0.000969	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CX3CL1—atherosclerosis	5.41e-05	0.00095	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CX3CR1—atherosclerosis	5.39e-05	0.000948	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CASR—atherosclerosis	5.39e-05	0.000948	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—EDN1—atherosclerosis	5.36e-05	0.000941	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	5.35e-05	0.000941	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—CCL5—atherosclerosis	5.32e-05	0.000934	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CX3CL1—atherosclerosis	5.29e-05	0.00093	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—EDN1—atherosclerosis	5.24e-05	0.000921	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—CCL5—atherosclerosis	5.2e-05	0.000914	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	5.16e-05	0.000906	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CNR2—atherosclerosis	5.13e-05	0.000901	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—CXCL8—atherosclerosis	5.12e-05	0.0009	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—MMP3—atherosclerosis	5.12e-05	0.000899	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PRKCG—atherosclerosis	5.05e-05	0.000888	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CNR2—atherosclerosis	5.02e-05	0.000881	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—CXCL8—atherosclerosis	5.01e-05	0.000881	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—MMP3—atherosclerosis	5e-05	0.000879	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PRKCG—atherosclerosis	4.94e-05	0.000869	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—EDN1—atherosclerosis	4.87e-05	0.000855	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CCL5—atherosclerosis	4.83e-05	0.000848	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—EDN1—atherosclerosis	4.76e-05	0.000836	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CCL5—atherosclerosis	4.72e-05	0.00083	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ABCG1—atherosclerosis	4.72e-05	0.000829	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	4.65e-05	0.000817	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PRKCG—atherosclerosis	4.59e-05	0.000807	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—VWF—atherosclerosis	4.57e-05	0.000803	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	4.57e-05	0.000803	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—APOC3—atherosclerosis	4.54e-05	0.000798	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—LDLR—atherosclerosis	4.51e-05	0.000793	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PRKCG—atherosclerosis	4.49e-05	0.000789	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—VWF—atherosclerosis	4.47e-05	0.000785	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—AGT—atherosclerosis	4.45e-05	0.000781	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—APOC3—atherosclerosis	4.44e-05	0.000781	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—LCAT—atherosclerosis	4.44e-05	0.00078	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—FABP4—atherosclerosis	4.44e-05	0.00078	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—LDLR—atherosclerosis	4.42e-05	0.000776	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CCL3—atherosclerosis	4.41e-05	0.000775	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	4.39e-05	0.000771	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—APOA4—atherosclerosis	4.36e-05	0.000765	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—AGT—atherosclerosis	4.35e-05	0.000764	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCL3—atherosclerosis	4.31e-05	0.000758	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP7A1—atherosclerosis	4.28e-05	0.000752	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NCF1—atherosclerosis	4.22e-05	0.000742	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	4.22e-05	0.000741	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NCF1—atherosclerosis	4.13e-05	0.000726	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—F2—atherosclerosis	4.11e-05	0.000722	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	4.05e-05	0.000711	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—AGT—atherosclerosis	4.04e-05	0.00071	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—F2—atherosclerosis	4.02e-05	0.000706	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	3.99e-05	0.000701	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CCR2—atherosclerosis	3.99e-05	0.000701	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—EDNRA—atherosclerosis	3.99e-05	0.000701	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CYBA—atherosclerosis	3.97e-05	0.000698	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP27A1—atherosclerosis	3.95e-05	0.000695	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—AGT—atherosclerosis	3.95e-05	0.000694	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PIK3CG—atherosclerosis	3.93e-05	0.000691	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—EDNRA—atherosclerosis	3.9e-05	0.000685	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCR2—atherosclerosis	3.9e-05	0.000685	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PARP1—atherosclerosis	3.89e-05	0.000683	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GHRL—atherosclerosis	3.89e-05	0.000683	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PLAT—atherosclerosis	3.89e-05	0.000683	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CYBA—atherosclerosis	3.88e-05	0.000682	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	3.88e-05	0.000681	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	3.87e-05	0.00068	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PIK3CG—atherosclerosis	3.85e-05	0.000676	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PARP1—atherosclerosis	3.8e-05	0.000668	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GHRL—atherosclerosis	3.8e-05	0.000668	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PLAT—atherosclerosis	3.8e-05	0.000668	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ALOX5AP—atherosclerosis	3.75e-05	0.000659	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ALOX15—atherosclerosis	3.75e-05	0.000659	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PLA2G2A—atherosclerosis	3.75e-05	0.000659	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—APOA2—atherosclerosis	3.75e-05	0.000659	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—F2—atherosclerosis	3.73e-05	0.000656	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ABCG5—atherosclerosis	3.7e-05	0.000651	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—F2—atherosclerosis	3.65e-05	0.000641	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	3.61e-05	0.000635	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—LPA—atherosclerosis	3.58e-05	0.000628	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PIK3CG—atherosclerosis	3.57e-05	0.000628	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PIK3CG—atherosclerosis	3.49e-05	0.000614	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—BGN—atherosclerosis	3.46e-05	0.000609	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—APOA5—atherosclerosis	3.43e-05	0.000602	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—KNG1—atherosclerosis	3.41e-05	0.000599	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—AGTR1—atherosclerosis	3.39e-05	0.000596	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—KNG1—atherosclerosis	3.34e-05	0.000586	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CCL2—atherosclerosis	3.33e-05	0.000584	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AGTR1—atherosclerosis	3.32e-05	0.000583	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PLG—atherosclerosis	3.3e-05	0.000581	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PLA2G1B—atherosclerosis	3.3e-05	0.00058	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.27e-05	0.000575	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CCL2—atherosclerosis	3.25e-05	0.000572	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PLG—atherosclerosis	3.23e-05	0.000568	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ALOX5—atherosclerosis	3.19e-05	0.00056	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SOCS3—atherosclerosis	3.13e-05	0.00055	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.07e-05	0.000539	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SOCS3—atherosclerosis	3.06e-05	0.000538	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MMP3—atherosclerosis	3.02e-05	0.000531	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IGF2—atherosclerosis	3.01e-05	0.000529	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MMP3—atherosclerosis	2.96e-05	0.000519	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IGF2—atherosclerosis	2.94e-05	0.000517	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—APOB—atherosclerosis	2.92e-05	0.000513	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—CXCL8—atherosclerosis	2.9e-05	0.000509	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—EDN1—atherosclerosis	2.87e-05	0.000505	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NAMPT—atherosclerosis	2.86e-05	0.000502	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—APOB—atherosclerosis	2.86e-05	0.000502	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CCL5—atherosclerosis	2.85e-05	0.000501	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—LIPC—atherosclerosis	2.84e-05	0.000499	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	2.83e-05	0.000498	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—APOC3—atherosclerosis	2.82e-05	0.000496	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—EDN1—atherosclerosis	2.81e-05	0.000494	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—LDLR—atherosclerosis	2.81e-05	0.000493	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCL5—atherosclerosis	2.79e-05	0.00049	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—LPL—atherosclerosis	2.79e-05	0.00049	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CETP—atherosclerosis	2.74e-05	0.000482	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—LPL—atherosclerosis	2.73e-05	0.000479	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PRKCG—atherosclerosis	2.71e-05	0.000476	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	2.69e-05	0.000473	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	2.65e-05	0.000466	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SPP1—atherosclerosis	2.64e-05	0.000464	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CXCL8—atherosclerosis	2.63e-05	0.000462	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SCARB1—atherosclerosis	2.62e-05	0.000461	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SPP1—atherosclerosis	2.58e-05	0.000454	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	2.57e-05	0.000452	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—HMGCR—atherosclerosis	2.48e-05	0.000436	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PDGFB—atherosclerosis	2.44e-05	0.000429	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	2.43e-05	0.000427	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	2.39e-05	0.00042	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—AGT—atherosclerosis	2.39e-05	0.000419	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—APOE—atherosclerosis	2.34e-05	0.000411	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—LEP—atherosclerosis	2.34e-05	0.000411	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AGT—atherosclerosis	2.33e-05	0.00041	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CAV1—atherosclerosis	2.32e-05	0.000407	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—APOA1—atherosclerosis	2.31e-05	0.000406	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—LEP—atherosclerosis	2.29e-05	0.000402	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—APOE—atherosclerosis	2.29e-05	0.000402	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CAV1—atherosclerosis	2.27e-05	0.000398	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—APOA1—atherosclerosis	2.26e-05	0.000397	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ESR1—atherosclerosis	2.23e-05	0.000392	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ABCA1—atherosclerosis	2.21e-05	0.000388	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—F2—atherosclerosis	2.2e-05	0.000387	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ESR1—atherosclerosis	2.18e-05	0.000384	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—F2—atherosclerosis	2.16e-05	0.000379	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PIK3CG—atherosclerosis	2.11e-05	0.000371	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	2.06e-05	0.000363	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	2.02e-05	0.000355	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—INS—atherosclerosis	2e-05	0.000351	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	1.98e-05	0.000347	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CCL2—atherosclerosis	1.96e-05	0.000345	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—INS—atherosclerosis	1.95e-05	0.000343	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IGF1—atherosclerosis	1.93e-05	0.000339	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCL2—atherosclerosis	1.92e-05	0.000338	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—HMOX1—atherosclerosis	1.9e-05	0.000333	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IGF1—atherosclerosis	1.89e-05	0.000332	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	1.83e-05	0.000322	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—APOB—atherosclerosis	1.82e-05	0.000319	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	1.79e-05	0.000315	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GSTM1—atherosclerosis	1.77e-05	0.00031	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NOS3—atherosclerosis	1.75e-05	0.000308	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—LPL—atherosclerosis	1.73e-05	0.000305	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NOS3—atherosclerosis	1.71e-05	0.000301	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GPX1—atherosclerosis	1.69e-05	0.000297	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CD36—atherosclerosis	1.65e-05	0.000289	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—MTHFR—atherosclerosis	1.56e-05	0.000274	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	1.55e-05	0.000273	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PPARA—atherosclerosis	1.53e-05	0.000269	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	1.52e-05	0.000267	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	1.5e-05	0.000264	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—AGT—atherosclerosis	1.48e-05	0.000261	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—IL6—atherosclerosis	1.48e-05	0.00026	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	1.47e-05	0.000258	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—APOE—atherosclerosis	1.45e-05	0.000255	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—IL6—atherosclerosis	1.44e-05	0.000254	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CAV1—atherosclerosis	1.44e-05	0.000253	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—APOA1—atherosclerosis	1.44e-05	0.000252	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MMP9—atherosclerosis	1.41e-05	0.000247	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	1.39e-05	0.000244	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MMP9—atherosclerosis	1.37e-05	0.000242	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	1.37e-05	0.00024	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	1.36e-05	0.000239	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	1.36e-05	0.000239	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	1.34e-05	0.000235	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	1.33e-05	0.000234	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PIK3CG—atherosclerosis	1.31e-05	0.00023	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PPARG—atherosclerosis	1.27e-05	0.000222	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	1.26e-05	0.000222	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—STAT3—atherosclerosis	1.25e-05	0.00022	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—INS—atherosclerosis	1.24e-05	0.000218	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	1.23e-05	0.000217	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—STAT3—atherosclerosis	1.22e-05	0.000215	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	1.19e-05	0.00021	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	1.17e-05	0.000205	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	1.16e-05	0.000203	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ALB—atherosclerosis	1.14e-05	0.0002	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	1.13e-05	0.000199	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NOS3—atherosclerosis	1.09e-05	0.000191	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PTGS2—atherosclerosis	9.96e-06	0.000175	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IL6—atherosclerosis	8.73e-06	0.000153	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IL6—atherosclerosis	8.54e-06	0.00015	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—AKT1—atherosclerosis	8.05e-06	0.000141	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AKT1—atherosclerosis	7.87e-06	0.000138	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—AKT1—atherosclerosis	5e-06	8.79e-05	CbGpPWpGaD
